Cell/Gene Tx channel feed – Endpoints News

Cell/Gene Tx channel feed

FDA experts offer a unanimous endorsement for Spark’s pioneering AAV gene therapy for blindness

8 years ago

Spark Therapeutics faces a grilling as FDA ponders a pioneering OK for gene therapy

8 years ago

Bluebird’s gene therapy shows promise in keeping lethal Lorenzo’s Oil disease in check

8 years ago

Voyager Therapeutics adds proof its gene therapy for Parkinson's can work, shares soar

8 years ago

Big names, big companies back a cell therapy startup run by a high-profile regenerative med expert

8 years ago

Orbimed partner in search of a cure for Parkinson’s launches new gene therapy player

8 years ago

Spark Therapeutics offers a glimpse of efficacy in first two hemophilia A gene therapy patients

8 years ago

FDA embraces the first US application for a gene therapy, offering an accelerated test case

8 years ago

Pioneering gene therapy patients stay on track, boosting Spark’s hemophilia B program

8 years ago

Bluebird bio steps up with a promising snapshot of its gene therapy upgrade

9 years ago

Pfizer expands gene therapy effort on hemophilia, bagging rights to a Sangamo drug in a $545M deal

9 years ago

Spark carefully records a safe step forward for closely-watched hemophilia gene therapy

9 years ago

Solid Biosciences appears to be prepping for an IPO with $50M round for Duchenne gene therapy

9 years ago

A gene therapy pioneer moves from Biogen to Regenxbio, staying focused on gene therapy 2.0

9 years ago

Months after another lethal setback, Juno finally opts to kill lead CAR-T

9 years ago

A better gene therapy vector out of Harvard is credited with restoring normal hearing in mice

9 years ago

In wake of a CAR-T restructuring, Novartis says it’s ready to hunt a pioneering OK for lead program

9 years ago

Spark’s delivery vector triggers another troubling immune reaction, but R&D team maintains hemophilia B efficacy

9 years ago

Bluebird, Celgene jump off to a promising start in the marathon race to develop a CAR-T for multiple myeloma

9 years ago

Kite grabs a stem cell biology ‘breakthrough’ in race for off-the-shelf T cell therapies

9 years ago

First page Previous page 56 57 5859